期刊文献+

液相色谱-质谱-质谱联用技术同时测定犬血浆中头孢哌酮钠和他唑巴坦钠 被引量:3

Determination of the Content of Cefoperazone Sodium and Tazobactam Sodium in Dog Plasma by Liquid Chromatography-tandem Mass Spectrometry
下载PDF
导出
摘要 目的:建立快速测定犬血浆中头孢哌酮钠和他唑巴坦钠含量的液相色谱-质谱-质谱(LC-MS-MS)联用方法。方法:血浆样品经甲醇沉淀蛋白后,以乙腈-水-甲酸(25:75:1.5)为流动相,流速0.2mL·min^(-1),采用 C_(18)柱分离,通过电喷雾化的四极杆串联质谱,以多离子反应监测(MRM)方式进行检测。用于定量分析的二级碎片离子分别为 m/z 530(头孢哌酮钠)和 m/z 168(他唑巴坦钠)。结果:头孢哌酮钠和他唑巴坦钠的线性范围分别为1~500μg·mL^(-1)和1~200μg·mL^(-1),每个样品测试时间为6 min。结论:该方法快速、准确,专属性强,操作简便,可用于犬血浆中头孢哌酮钠和他唑巴坦钠含量的测定及其临床药动学研究。 Objective:To develop a rapid and sensitive liquid -chromatography -tandem mass spectrometry (LC - MS- MS)method for determination of cefoperazone sodium and tazobactam sodium in dog plasma. Method:From 0. 4 mL plasma, cefoperazone and tazobactam were extracted with 0. 8 mL methanol, followed by liquid chromatography separation and mass spectrometric detection. The mobile phase consisted of acetronitrile -water -formic acid (25: 75: 1.5 ), at a flow rate of 0. 2 mL · min^-1. Electrospray ionization (ESI) source was applied and operated in the positive ion mode. The multiple reaction monitoring( MRM )mode use the transitions of m/z 646→530 and m/z 301→168 were used to quantify the cefoperazone and the tazobactam, respectively. Results: The assay was linear from 1 to 500 μg · mL ^-1 (cefoperazone) and from 1 to 200 μg · mL^-1 (tazobactam). The RSDs were less than 11% and 8% ,respectively. Conclusion:The method is shown to be suitable for clinical investigation of cefoperazone sodium tazobactam sodium pharmacokinetics, which offers advantages of specificity, speed and simpleness.
出处 《药物分析杂志》 CAS CSCD 北大核心 2005年第11期1387-1390,共4页 Chinese Journal of Pharmaceutical Analysis
关键词 头孢哌酮钠 他唑巴坦钠 液相色谱-质谱-质谱 血浆 cefoperazone sodium tazobactam sodium liquid chromatography tandem mass spectrometry (LC - MS - MS) plasma
  • 相关文献

参考文献10

二级参考文献8

共引文献26

同被引文献35

  • 1廖佳佳,胡宏灿.原子吸收分光光度法测定饲料原料铜、锰、锌、铅的两种前处理方法比较研究[J].化学工程与装备,2008(4):126-128. 被引量:6
  • 2孟湘明,孟志云,张亮,窦桂芳.Simultaneous Determination of Ceftazidime and Tazobactam in Injectable Powder by Reversed-Phase High Performance Liquid Chromatography[J].Journal of Chinese Pharmaceutical Sciences,2004,13(4):267-270. 被引量:2
  • 3李方方,顾世芬,陈汇.静脉滴注头孢哌酮/他唑巴坦复方制剂的健康人体药动学[J].中国药学杂志,2007,42(15):1181-1184. 被引量:3
  • 4Aronoff SC, Jacobs MR, Johenning S, et al. Comparative activities of the beta - lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin. Antimicrob Agents Chemother, 1984,26 (4) : 580.
  • 5Bethel CR, Hujer AM, Helfand MS,et al. Exploring the effectiveness of tazobactam against ceftazidime resistant Escherichia coli:insights from the comparison between susceptibility testing and beta - lacta- mase inhibition. FEMS Microbiol Lett ,2004,234 ( 1 ) :99.
  • 6Guitton J, Laffont A, Bruzeau J, et al. Determination of ceftazidime in plasma using high - performance liquid chromatography and elec- trochemical detection-Application for individualizing dosage regi- mens in elderly patients. J Chromatogr B,1998,719(1 -2) :151.
  • 7Isla A, Arzuaga A, Maynar J, et al. Determination of ceftazidime and cefepime in plasma and dialysate - ultra filtrate from patients undergoing continuous veno - venous hernodiafihration by HPLC. J Pharm Biomed Anal,2005,39(5) :996.
  • 8Ehrlich M, Daschner FD, Ktimmerer K. Rapid antibiotic drug moni- toring:meropenem and ceftazidime determination in serum and bronchial secretions by highperformance liquid chromatography - inte- grated sample preparation. J Chromatogr B, 2001,751 ( 2 ) : 357.
  • 9Guillanme Y, Peyrin E, Guinchard C. Rapid determination of sulbactam and tazobactam in human serum by high - performance liquid chromatography. J Chromatogr B, 1995,665 (2) : 363.
  • 10GUOBei-ning(郭蓓宁) WUXiao-jie(武晓捷) ZHANGJing(张菁).Simultaneous determination of cefoperazone and tazobactam in hu- man plasma and urine using liquid chromatography electrospray ioniza- tion tandem mass speetrometry(LC-MS/MS法同时检测人血浆及尿液中头孢哌酮和他唑巴坦含量)[J].质谱学报,2007,28:79-79.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部